mo091715_hires-5.jpg

REGENXBIO Inc. [RGNX], a leading biotechnology company in gene therapy, opened for trading on The Nasdaq Stock Market on September 17, 2015.

Format

JPEG

Source

Nasdaq, Inc.

Téléchargements